These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 15528467

  • 1. Induction of the MMP-14 gene in macrophages of the atherosclerotic plaque: role of SAF-1 in the induction process.
    Ray BK, Shakya A, Turk JR, Apte SS, Ray A.
    Circ Res; 2004 Nov 26; 95(11):1082-90. PubMed ID: 15528467
    [Abstract] [Full Text] [Related]

  • 2. Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis.
    Ray A, Kuroki K, Cook JL, Bal BS, Kenter K, Aust G, Ray BK.
    Arthritis Rheum; 2003 Jan 26; 48(1):134-45. PubMed ID: 12528113
    [Abstract] [Full Text] [Related]

  • 3. Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins.
    Furman C, Rundlöf AK, Larigauderie G, Jaye M, Bricca G, Copin C, Kandoussi AM, Fruchart JC, Arnér ES, Rouis M.
    Free Radic Biol Med; 2004 Jul 01; 37(1):71-85. PubMed ID: 15183196
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ, Billiet L, Cuaz-Pérolin C, Slimane MN, Rouis M.
    Exp Cell Res; 2008 Nov 01; 314(18):3405-14. PubMed ID: 18823978
    [Abstract] [Full Text] [Related]

  • 5. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes.
    Ardans JA, Economou AP, Martinson JM, Zhou M, Wahl LM.
    J Leukoc Biol; 2002 Jun 01; 71(6):1012-8. PubMed ID: 12050187
    [Abstract] [Full Text] [Related]

  • 6. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide.
    Ray BK, Ray A.
    Biochemistry; 1997 Apr 15; 36(15):4662-8. PubMed ID: 9109677
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D, Masri S, Ye JJ, Chen S.
    Gene; 2005 Nov 21; 361():89-100. PubMed ID: 16181749
    [Abstract] [Full Text] [Related]

  • 8. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes.
    Hua Y, Xue J, Sun F, Zhu L, Xie M.
    Pharmacology; 2009 Nov 21; 83(1):18-25. PubMed ID: 18971601
    [Abstract] [Full Text] [Related]

  • 9. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z, Maher VM, McCormick JJ.
    Gene; 2005 May 23; 351():51-9. PubMed ID: 15857802
    [Abstract] [Full Text] [Related]

  • 10. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M, Suriyaphol P, Paprotka K, Spath L, Ochsenhirt V, Schmitt A, Han SR, Husmann M, Gerl VB, Bhakdi S, Lackner KJ.
    Arterioscler Thromb Vasc Biol; 2004 Nov 23; 24(11):2130-6. PubMed ID: 15345515
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
    Raymond L, Eck S, Mollmark J, Hays E, Tomek I, Kantor S, Elliott S, Vincenti M.
    J Cell Physiol; 2006 Jun 23; 207(3):683-8. PubMed ID: 16453302
    [Abstract] [Full Text] [Related]

  • 12. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H, Ye H, Mashima H, Bell GI.
    Gene; 2005 Jan 03; 344():143-59. PubMed ID: 15656981
    [Abstract] [Full Text] [Related]

  • 13. Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability.
    Speidl WS, Toller WG, Kaun C, Weiss TW, Pfaffenberger S, Kastl SP, Furnkranz A, Maurer G, Huber K, Metzler H, Wojta J.
    FASEB J; 2004 Mar 03; 18(3):603-5. PubMed ID: 14715701
    [Abstract] [Full Text] [Related]

  • 14. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
    Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schömig A, May AE.
    Thromb Haemost; 2006 Jan 03; 95(1):151-8. PubMed ID: 16543974
    [Abstract] [Full Text] [Related]

  • 15. Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages.
    Huang YC, Chang WC, Su JG, Cai JL, Chen CC, Hung JJ, Liu YW.
    J Biomed Sci; 2007 May 03; 14(3):407-18. PubMed ID: 17273900
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines.
    Uzui H, Harpf A, Liu M, Doherty TM, Shukla A, Chai NN, Tripathi PV, Jovinge S, Wilkin DJ, Asotra K, Shah PK, Rajavashisth TB.
    Circulation; 2002 Dec 10; 106(24):3024-30. PubMed ID: 12473546
    [Abstract] [Full Text] [Related]

  • 17. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T, Zeng G, Gao L, Yu RK.
    Gene; 2005 May 23; 351():109-18. PubMed ID: 15890474
    [Abstract] [Full Text] [Related]

  • 18. Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits.
    Liang J, Liu E, Yu Y, Kitajima S, Koike T, Jin Y, Morimoto M, Hatakeyama K, Asada Y, Watanabe T, Sasaguri Y, Watanabe S, Fan J.
    Circulation; 2006 Apr 25; 113(16):1993-2001. PubMed ID: 16636188
    [Abstract] [Full Text] [Related]

  • 19. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N, Mojsin M, Krstic A, Stevanovic M.
    Gene; 2005 Jan 03; 344():287-97. PubMed ID: 15656994
    [Abstract] [Full Text] [Related]

  • 20. Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability.
    Zhou YJ, Wang JH, Li L, Yang HW, Wen de L, He QC.
    Biochem Biophys Res Commun; 2007 Nov 09; 363(1):30-6. PubMed ID: 17825794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.